Drug Profile
Japanese encephalitis vaccine - VABIOTECH
Alternative Names: BR-209; JACEVAX; Vero Cell - Derived Inactivated Japanese Encephalitis VaccineLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Inviragen
- Developer VABIOTECH
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Japanese encephalitis
Most Recent Events
- 24 Sep 2020 No development reported - Phase-II for Japanese encephalitis (In infants, Prevention) in Vietnam (SC)
- 24 Sep 2020 No development reported - Phase-III for Japanese encephalitis (In infants, Prevention) in Vietnam (SC)
- 18 Sep 2017 National Institute of Hygiene and Epidemiology plans the JECEVAX-3 phase III trial for Japanese Encephalitis (In infants, In children) in Vietnam (NCT03282370)